Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations

Breast Cancer Res Treat. 2022 Jan;191(1):221. doi: 10.1007/s10549-021-06380-8.

Naoko Hashimoto Takigami^{1

2}, Shimpei Kuniyoshi^{1

3}, Yasuhiro Miki¹, Kentaro Tamaki^{1

2}, Yoshihiko Kamada², Kano Uehara², Seiko Tsuchiya², Shigeharu Terukina², Erina Iwabuchi¹, Ayako Kanai^{1

4}, Minoru Miyashita⁴, Takanori Ishida⁴, Nobumitsu Tamaki², Hironobu Sasano^{5

6}

¹ Department of Pathology, Tohoku University Graduate School of Medicine, 2‑1 Seiryo‑machi, Aoba‑ku, Sendai, Miyagi, 980-8575, Japan.
² Department of Breast Surgical Oncology, Nahanishi Clinic, Naha, Okinawa, Japan.
³ Department of Pathology, Tohoku University Hospital, Sendai, Miyagi, Japan.
⁴ Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
⁵ Department of Pathology, Tohoku University Graduate School of Medicine, 2‑1 Seiryo‑machi, Aoba‑ku, Sendai, Miyagi, 980-8575, Japan. hsasano@patholo2.med.tohoku.ac.jp.
⁶ Department of Pathology, Tohoku University Hospital, Sendai, Miyagi, Japan. hsasano@patholo2.med.tohoku.ac.jp.

No abstract available

Publication types